Your browser doesn't support javascript.
loading
Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survival.
Matson, Scott M; Ngo, Linh T; Sugawara, Yui; Fernando, Veani; Lugo, Claudia; Azeem, Imaan; Harrison, Alexis; Alsup, Alex; Nissen, Emily; Koestler, Devin; Washburn, Michael P; Rekowski, Michaella J; Wolters, Paul J; Lee, Joyce S; Solomon, Joshua J; Demoruelle, M Kristen.
Affiliation
  • Matson SM; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Ngo LT; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Sugawara Y; Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan.
  • Fernando V; Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Lugo C; Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Azeem I; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Harrison A; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Alsup A; Department of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Nissen E; Department of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Koestler D; Department of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Washburn MP; Department of Cancer Biology, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Rekowski MJ; Department of Cancer Biology, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Wolters PJ; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA.
  • Lee JS; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, USA.
  • Solomon JJ; Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health Hospital, Denver, CO.
  • Demoruelle MK; Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
medRxiv ; 2024 May 02.
Article in En | MEDLINE | ID: mdl-38343853
ABSTRACT

Background:

Idiopathic pulmonary fibrosis (IPF) leads to progressive loss of lung function and mortality. Understanding mechanisms and markers of lung injury in IPF is paramount to improving outcomes for these patients. Despite the lack of systemic involvement in IPF, many analyses focus on identifying circulating prognostic markers. Using a proteomic discovery method followed by ELISA validation in multiple IPF lung compartments and cohorts we explored novel markers of IPF survival.

Methods:

In our discovery analysis, agnostic label-free quantitative proteomics differentiated lung tissue protein expression based on survival trajectory (n=10). Following selection of the candidate pathway (neutrophil extracellular trap (NET) formation), we subsequently validated the presence of NETs in the IPF lung microenvironment using fully quantitative assays of known NET remnants in separate IPF cohorts (n=156 and n=52) with bronchoalveolar lavage fluid. We then assessed the correlation of these markers with baseline pulmonary function and survival.

Results:

Discovery lung tissue proteomics identified NET formation as significantly associated with poor IPF survival. Using fully quantitative confirmatory tests for reproducibility we confirmed the presence of NET markers in IPF BALF and found significant correlations with worse pulmonary function in both cohorts (p<0.03 and p = 0.04 respectively). In the survival cohort, higher levels of NET markers predicted worse survival after adjusting for gender, age, and baseline physiologic severity (hazard ratio range 1.79-2.19).

Conclusions:

NET markers were associated with disease severity and worse survival in IPF. These findings suggest NET formation contributes to lung injury and decreased survival in IPF and may represent a potential therapeutic target.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: MedRxiv Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: MedRxiv Year: 2024 Document type: Article Affiliation country: Country of publication: